Related Experiment Video
Updated: Jul 6, 2026
06:34
An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Update on influenza anti-virals
1Yong Loo Lin School of Medicine, National University of Singapore, Singapore. mdcpat@nus.edu.sg
Respirology (Carlton, Vic.)
|April 17, 2008
Summary
Antiviral drugs will be crucial for the initial response to a global influenza pandemic. Vaccines may not be ready in time for the first wave, making antivirals the primary defense alongside public health measures.
Area of Science:
- Epidemiology
- Virology
- Public Health
Background:
- Vaccines are the traditional method for controlling viral infections.
- The rapid spread of a global pandemic often outpaces vaccine development.
- Non-pharmacological interventions are important but may be insufficient alone.
Purpose of the Study:
- To highlight the critical role of antiviral medications in the early stages of an influenza pandemic.
- To emphasize the limitations of vaccine availability during the initial phase of a pandemic.
Main Methods:
- This study is a review of current pandemic preparedness strategies.
- It analyzes the timeline of vaccine development versus pandemic spread.
- It assesses the role of antivirals in conjunction with public health measures.
Main Results:
- An effective influenza vaccine is unlikely to be available for the first wave of a pandemic.
- Antiviral drugs represent the first line of medical intervention.
- Public health and infection control measures are essential complements to antiviral use.
Conclusions:
- Antiviral therapies are indispensable for managing the initial impact of influenza pandemics.
- Pandemic response plans must prioritize the rapid deployment of antiviral medications.
- A multi-faceted approach combining antivirals, vaccines, and public health measures is necessary for effective pandemic control.
